Fusion protein with specific bond to human interleukin-4, nucleic acid molecule, monoclonal antibodies, pharmaceutical composition and their use

A fusion protein having binding specificity for human interleukin-4 (IL-4) which comprises complementarity determining regions (CDRs) derived from a non-human neutralizing monoclonal antibody with a dissociation constant equal to or less than 2.10exp(-10) M, and a first fusion partner. A nucleic aci...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	HOLMES STEPHEN DUDLEY, SYLVESTER DANIEL R, GROSS MITCHELL STUART
Format:	Patent
Sprache:	eng ; slo
Schlagworte:	BEER BIOCHEMISTRY CHEMISTRY COMPOSITIONS THEREOF CULTURE MEDIA DERIVATIVES THEREOF ENZYMOLOGY FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIREDCHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERSFROM A RACEMIC MIXTURE HUMAN NECESSITIES HYGIENE INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIRCHEMICAL OR PHYSICAL PROPERTIES MEASURING MEDICAL OR VETERINARY SCIENCE METALLURGY MICROBIOLOGY MICROORGANISMS OR ENZYMES MUTATION OR GENETIC ENGINEERING NUCLEIC ACIDS NUCLEOSIDES NUCLEOTIDES ORGANIC CHEMISTRY PEPTIDES PHYSICS PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS SPIRITS SUGARS TESTING VINEGAR WINE
Online-Zugang:	Volltext bestellen
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

container_end_page
container_issue
container_start_page
container_title
container_volume
creator	HOLMES STEPHEN DUDLEY SYLVESTER DANIEL R GROSS MITCHELL STUART
description	A fusion protein having binding specificity for human interleukin-4 (IL-4) which comprises complementarity determining regions (CDRs) derived from a non-human neutralizing monoclonal antibody with a dissociation constant equal to or less than 2.10exp(-10) M, and a first fusion partner. A nucleic acid molecule encoding a fusion protein, monoclonal antibodies, pharmaceutical compositions comprising its and their use. Fúzny proteín so špecifickou väzbou na ľudský interleukín-4 (IL4), obsahujúci komplementárnosť určujúce oblasti (CDRs), odvodené z neutralizačnej monoklonálnej protilátky, nepochádzajúcej od človeka,s disociačnou konštantou rovnajúcou sa alebo menšou ako 2.10-10 M pre IL4 človeka, a prvým fúznym partnerom. Molekula nukleovej kyseliny kódujúca fúzny proteín, monoklonálne protilátky, farmaceutickékompozície s ich obsahom a ich použitie.
format	Patent
fullrecord	<record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_SK285556BB6</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>SK285556BB6</sourcerecordid><originalsourceid>FETCH-epo_espacenet_SK285556BB63</originalsourceid><addsrcrecordid>eNqNjUsKwkAQRLNxIeod-gDJRk1wHTEILnUfJp0OaZzpHuaD1_DIRvAArqqgHvXWxbvLkVXAB03EAi9OM0RPyBMjDCojJIU5OyPAkihYyk-W6liCZLS0QAZ5BKeWMFsqlyaKVsVYMJJ40JEpluBnE5xByolxmVCd18jp6zZfyUwcIEfaFqvJ2Ei7X24K6C6P87Uirz1Fv1wIpf5-25_qum7atjn8gXwAAj9PVQ</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>Fusion protein with specific bond to human interleukin-4, nucleic acid molecule, monoclonal antibodies, pharmaceutical composition and their use</title><source>esp@cenet</source><creator>HOLMES STEPHEN DUDLEY ; SYLVESTER DANIEL R ; GROSS MITCHELL STUART</creator><creatorcontrib>HOLMES STEPHEN DUDLEY ; SYLVESTER DANIEL R ; GROSS MITCHELL STUART</creatorcontrib><description>A fusion protein having binding specificity for human interleukin-4 (IL-4) which comprises complementarity determining regions (CDRs) derived from a non-human neutralizing monoclonal antibody with a dissociation constant equal to or less than 2.10exp(-10) M, and a first fusion partner. A nucleic acid molecule encoding a fusion protein, monoclonal antibodies, pharmaceutical compositions comprising its and their use. Fúzny proteín so špecifickou väzbou na ľudský interleukín-4 (IL4), obsahujúci komplementárnosť určujúce oblasti (CDRs), odvodené z neutralizačnej monoklonálnej protilátky, nepochádzajúcej od človeka,s disociačnou konštantou rovnajúcou sa alebo menšou ako 2.10-10 M pre IL4 človeka, a prvým fúznym partnerom. Molekula nukleovej kyseliny kódujúca fúzny proteín, monoklonálne protilátky, farmaceutickékompozície s ich obsahom a ich použitie.</description><language>eng ; slo</language><subject>BEER ; BIOCHEMISTRY ; CHEMISTRY ; COMPOSITIONS THEREOF ; CULTURE MEDIA ; DERIVATIVES THEREOF ; ENZYMOLOGY ; FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIREDCHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERSFROM A RACEMIC MIXTURE ; HUMAN NECESSITIES ; HYGIENE ; INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIRCHEMICAL OR PHYSICAL PROPERTIES ; MEASURING ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; MICROBIOLOGY ; MICROORGANISMS OR ENZYMES ; MUTATION OR GENETIC ENGINEERING ; NUCLEIC ACIDS ; NUCLEOSIDES ; NUCLEOTIDES ; ORGANIC CHEMISTRY ; PEPTIDES ; PHYSICS ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS ; SPIRITS ; SUGARS ; TESTING ; VINEGAR ; WINE</subject><creationdate>2007</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20070301&DB=EPODOC&CC=SK&NR=285556B6$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,776,881,25543,76293</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20070301&DB=EPODOC&CC=SK&NR=285556B6$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>HOLMES STEPHEN DUDLEY</creatorcontrib><creatorcontrib>SYLVESTER DANIEL R</creatorcontrib><creatorcontrib>GROSS MITCHELL STUART</creatorcontrib><title>Fusion protein with specific bond to human interleukin-4, nucleic acid molecule, monoclonal antibodies, pharmaceutical composition and their use</title><description>A fusion protein having binding specificity for human interleukin-4 (IL-4) which comprises complementarity determining regions (CDRs) derived from a non-human neutralizing monoclonal antibody with a dissociation constant equal to or less than 2.10exp(-10) M, and a first fusion partner. A nucleic acid molecule encoding a fusion protein, monoclonal antibodies, pharmaceutical compositions comprising its and their use. Fúzny proteín so špecifickou väzbou na ľudský interleukín-4 (IL4), obsahujúci komplementárnosť určujúce oblasti (CDRs), odvodené z neutralizačnej monoklonálnej protilátky, nepochádzajúcej od človeka,s disociačnou konštantou rovnajúcou sa alebo menšou ako 2.10-10 M pre IL4 človeka, a prvým fúznym partnerom. Molekula nukleovej kyseliny kódujúca fúzny proteín, monoklonálne protilátky, farmaceutickékompozície s ich obsahom a ich použitie.</description><subject>BEER</subject><subject>BIOCHEMISTRY</subject><subject>CHEMISTRY</subject><subject>COMPOSITIONS THEREOF</subject><subject>CULTURE MEDIA</subject><subject>DERIVATIVES THEREOF</subject><subject>ENZYMOLOGY</subject><subject>FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIREDCHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERSFROM A RACEMIC MIXTURE</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIRCHEMICAL OR PHYSICAL PROPERTIES</subject><subject>MEASURING</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>MICROBIOLOGY</subject><subject>MICROORGANISMS OR ENZYMES</subject><subject>MUTATION OR GENETIC ENGINEERING</subject><subject>NUCLEIC ACIDS</subject><subject>NUCLEOSIDES</subject><subject>NUCLEOTIDES</subject><subject>ORGANIC CHEMISTRY</subject><subject>PEPTIDES</subject><subject>PHYSICS</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><subject>SPIRITS</subject><subject>SUGARS</subject><subject>TESTING</subject><subject>VINEGAR</subject><subject>WINE</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2007</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNqNjUsKwkAQRLNxIeod-gDJRk1wHTEILnUfJp0OaZzpHuaD1_DIRvAArqqgHvXWxbvLkVXAB03EAi9OM0RPyBMjDCojJIU5OyPAkihYyk-W6liCZLS0QAZ5BKeWMFsqlyaKVsVYMJJ40JEpluBnE5xByolxmVCd18jp6zZfyUwcIEfaFqvJ2Ei7X24K6C6P87Uirz1Fv1wIpf5-25_qum7atjn8gXwAAj9PVQ</recordid><startdate>20070301</startdate><enddate>20070301</enddate><creator>HOLMES STEPHEN DUDLEY</creator><creator>SYLVESTER DANIEL R</creator><creator>GROSS MITCHELL STUART</creator><scope>EVB</scope></search><sort><creationdate>20070301</creationdate><title>Fusion protein with specific bond to human interleukin-4, nucleic acid molecule, monoclonal antibodies, pharmaceutical composition and their use</title><author>HOLMES STEPHEN DUDLEY ; SYLVESTER DANIEL R ; GROSS MITCHELL STUART</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_SK285556BB63</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng ; slo</language><creationdate>2007</creationdate><topic>BEER</topic><topic>BIOCHEMISTRY</topic><topic>CHEMISTRY</topic><topic>COMPOSITIONS THEREOF</topic><topic>CULTURE MEDIA</topic><topic>DERIVATIVES THEREOF</topic><topic>ENZYMOLOGY</topic><topic>FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIREDCHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERSFROM A RACEMIC MIXTURE</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIRCHEMICAL OR PHYSICAL PROPERTIES</topic><topic>MEASURING</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>MICROBIOLOGY</topic><topic>MICROORGANISMS OR ENZYMES</topic><topic>MUTATION OR GENETIC ENGINEERING</topic><topic>NUCLEIC ACIDS</topic><topic>NUCLEOSIDES</topic><topic>NUCLEOTIDES</topic><topic>ORGANIC CHEMISTRY</topic><topic>PEPTIDES</topic><topic>PHYSICS</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><topic>SPIRITS</topic><topic>SUGARS</topic><topic>TESTING</topic><topic>VINEGAR</topic><topic>WINE</topic><toplevel>online_resources</toplevel><creatorcontrib>HOLMES STEPHEN DUDLEY</creatorcontrib><creatorcontrib>SYLVESTER DANIEL R</creatorcontrib><creatorcontrib>GROSS MITCHELL STUART</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>HOLMES STEPHEN DUDLEY</au><au>SYLVESTER DANIEL R</au><au>GROSS MITCHELL STUART</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>Fusion protein with specific bond to human interleukin-4, nucleic acid molecule, monoclonal antibodies, pharmaceutical composition and their use</title><date>2007-03-01</date><risdate>2007</risdate><abstract>A fusion protein having binding specificity for human interleukin-4 (IL-4) which comprises complementarity determining regions (CDRs) derived from a non-human neutralizing monoclonal antibody with a dissociation constant equal to or less than 2.10exp(-10) M, and a first fusion partner. A nucleic acid molecule encoding a fusion protein, monoclonal antibodies, pharmaceutical compositions comprising its and their use. Fúzny proteín so špecifickou väzbou na ľudský interleukín-4 (IL4), obsahujúci komplementárnosť určujúce oblasti (CDRs), odvodené z neutralizačnej monoklonálnej protilátky, nepochádzajúcej od človeka,s disociačnou konštantou rovnajúcou sa alebo menšou ako 2.10-10 M pre IL4 človeka, a prvým fúznym partnerom. Molekula nukleovej kyseliny kódujúca fúzny proteín, monoklonálne protilátky, farmaceutickékompozície s ich obsahom a ich použitie.</abstract><oa>free_for_read</oa></addata></record>
fulltext	fulltext_linktorsrc
identifier
ispartof
issn
language	eng ; slo
recordid	cdi_epo_espacenet_SK285556BB6
source	esp@cenet
subjects	BEER BIOCHEMISTRY CHEMISTRY COMPOSITIONS THEREOF CULTURE MEDIA DERIVATIVES THEREOF ENZYMOLOGY FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIREDCHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERSFROM A RACEMIC MIXTURE HUMAN NECESSITIES HYGIENE INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIRCHEMICAL OR PHYSICAL PROPERTIES MEASURING MEDICAL OR VETERINARY SCIENCE METALLURGY MICROBIOLOGY MICROORGANISMS OR ENZYMES MUTATION OR GENETIC ENGINEERING NUCLEIC ACIDS NUCLEOSIDES NUCLEOTIDES ORGANIC CHEMISTRY PEPTIDES PHYSICS PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS SPIRITS SUGARS TESTING VINEGAR WINE
title	Fusion protein with specific bond to human interleukin-4, nucleic acid molecule, monoclonal antibodies, pharmaceutical composition and their use
url	https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-25T16%3A10%3A43IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=HOLMES%20STEPHEN%20DUDLEY&rft.date=2007-03-01&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3ESK285556BB6%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true